All News
🟢 Shoprite is trading 9% up today amid reported Investec partnership talks
Shoprite is trading at €19.30, up 9.04%, alongside Bloomberg-reported Investec partnership talks, which reporting did not explicitly link to the rise. -...
🟢 BEZ is trading 12.4% up
BEZ is trading at $8.14, up 12.4% from a comparison close of $7.24 during pre-market. This is a price-action follow-up, so a separate catalyst may not be...
OpenAI Launches Decisions API for 10x-Faster AI Tasks
OpenAI announced the general availability of its Decisions API on October 22, 2026, entering the market for fast, low-cost decision models. [1, 2, 7] Built on...
🔴 Mednax is trading 4.5% down in pre-market with no clear company-specific catalyst
Mednax is trading 4.5% down now at $28.22, with no clear company-specific announcement explaining the October 23 pre-market drop. - It closed at $29.55 on...
Achieve's Smoking-Cessation Drug Posts Solid Quit Rates — But Can It Clear the FDA's Manufacturing Hurdle in Time?
Shares of Achieve Life Sciences surged 11.5% to $7.25 in pre-market trading on October 23, bucking a weaker broader market, after the company presented new...
🔴 Stellantis is trading 4.01% down with no specific catalyst identified
Stellantis is trading 4.01% down at €3.64, with no reliable report directly linking the October 23 decline to a company announcement or catalyst. - European...
🟢 SPX is trading 5% up in pre-market
SPX is trading 5.31% higher in pre-market at $168.50, with no clear SPX-specific announcement explaining the move in the available October 23 news search. -...
🟢 San Juan Basin Royalty Trust is trading 5% up in pre-market; no clear catalyst
San Juan Basin Royalty Trust is trading at $3.54, up 5.04% in pre-market, with no clear company-specific announcement explaining the October 23 move...
Tompkins Financial Q3 EPS of $2.00 beats expectations as net interest margins expanded to 3.65%
Tompkins Financial reported third quarter 2026 results featuring a beat on both the top and bottom lines. Diluted earnings per share reached $2.00, surpassing...
🔴 3 E Network Technology Group is trading 5% down in pre-market with XLK down 2.30%
3 E Network Technology Group is trading at $0.83, down 5.38%, in pre-market on October 23, alongside technology ETF XLK’s 2.30% decline; no confirmed catalyst...
🟢 Nyxoah is trading 7% up in pre-market
Nyxoah is trading at $0.88, up 6.96%, with no clear company-specific news identified to explain the October 23 pre-market rise. - On October 19, Nyxoah...
🟢 MEDPAL AI is trading 6.52% up today, with healthcare-sector strength a possible tailwind
MEDPAL AI is trading at £4.90, up 6.52%, with healthcare-sector strength a possible tailwind. - No company-specific announcement explaining the October 23...
🔴 Micropolis Holding is trading 6.6% down in pre-market
Micropolis Holding is trading 6.61% down at $0.36 in pre-market; no verified company-specific announcement explaining the October 23 move was found. - The...
🟢 Fury Gold Mines is trading 5% up in pre-market with no clear catalyst
Fury Gold Mines is trading at $0.52, up 5.05%, with no clear company-specific catalyst identified. - Fury’s official releases page lists no October 2026...
🟢 Fortrea Holdings is trading 7% up in pre-market
Fortrea Holdings is trading 6.61% higher at $25.50 in pre-market, with no clear direct catalyst confirmed. - It closed at $23.92 on October 22. - On October...
Tempus AI Announces $192.5M Data Licensing Agreements with Bristol-Myers Squibb and Pathos AI
Tempus AI has entered into a series of agreements with Bristol-Myers Squibb (BMS) and Pathos AI to expand the use of its de-identified multimodal real-world...
🟢 Edesa Biotech is trading 14.86% up in pre-market
Edesa Biotech is trading at $3.17, up 14.86% in pre-market, with no clear catalyst identified. - No company-specific announcement dated October 23 was found...
🟢 Clearfield is trading 6.4% up in pre-market with no clear catalyst identified
Clearfield is trading at $29.25, up +6.36%, with no clear catalyst identified for the pre-market rise. - The latest company news was an October 20 CEO...
🟢 Achieve Life Sciences is trading 11.5% up in pre-market after positive 52-week ORCA-OL trial results
Achieve Life Sciences is trading 11.5% up at $7.25 in pre-market on October 23, following positive 52-week ORCA-OL cytisinicline trial results announced...
🟢 Arteris is trading 8.4% up in pre-market with no company-specific catalyst reported
Arteris is trading at $20.69, up 8.36%, in pre-market as shares rebound after the prior session’s decline; no new company-specific catalyst surfaced. -...